Financial reports
NT 10-Q
Notice of late quarterly filing
8 Apr 24
10-K
2023 FY
Annual report
19 Mar 24
NT 10-Q
Notice of late quarterly filing
10 Jan 24
NT 10-Q
Notice of late quarterly filing
10 Oct 23
NT 10-K
Notice of late annual filing
14 Aug 23
10-Q
2023 Q3
Quarterly report
2 Jun 23
NT 10-Q
Notice of late quarterly filing
10 Apr 23
10-Q
2023 Q2
Quarterly report
16 Mar 23
10-K/A
2022 FY
Annual report (amended)
16 Mar 23
Current reports
8-K
Results of Operations and Financial Condition
1 Apr 24
8-K
Changes in Registrant's Certifying Accountant
26 Mar 24
8-K
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
20 Mar 24
8-K
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
20 Mar 24
8-K
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
16 Feb 24
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
12 Jan 24
8-K
Entry into a Material Definitive Agreement
5 Jan 24
8-K
Regulation FD Disclosure
20 Nov 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
31 Oct 23
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
18 Oct 23
Registration and prospectus
424B3
Prospectus supplement
9 Jun 23
S-1/A
IPO registration (amended)
6 Jun 23
S-1
IPO registration
6 Apr 23
S-8
Registration of securities for employees
6 Apr 23
S-8
Registration of securities for employees
16 Oct 19
D
$19.36M in equity, sold $19.36M, 13 investors
6 Dec 18
S-8
Registration of securities for employees
20 Oct 17
S-3
Shelf registration
16 Oct 15
S-8
Registration of securities for employees
7 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jan 10
Proxies
DEF 14A
Definitive proxy
19 Sep 22
DEF 14A
Definitive proxy
27 Aug 21
DEF 14A
Definitive proxy
31 Aug 20
PRE 14A
Preliminary proxy
21 Aug 20
DEF 14A
Definitive proxy
21 Aug 19
DEF 14A
Definitive proxy
23 Aug 18
DEF 14A
Definitive proxy
24 Aug 17
DEF 14A
Definitive proxy
26 Aug 16
DEF 14A
Definitive proxy
24 Aug 15
DEF 14A
Definitive proxy
5 Sep 14
Other
EFFECT
Notice of effectiveness
12 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
UPLOAD
Letter from SEC
14 Apr 23
UPLOAD
Letter from SEC
10 Mar 21
CORRESP
Correspondence with SEC
8 Mar 21
CORRESP
Correspondence with SEC
16 Feb 21
UPLOAD
Letter from SEC
10 Feb 21
UPLOAD
Letter from SEC
22 Mar 18
CORRESP
Correspondence with SEC
14 Mar 18
UPLOAD
Letter from SEC
8 Mar 18
Ownership
SC 13D/A
22NW Fund, LP
29 Feb 24
SC 13G/A
DIMENSIONAL FUND ADVISORS LP
9 Feb 24
4
Joshua Schechter
2 Feb 24
4
Nathaniel Calloway
2 Feb 24
4
NELSON OBUS
2 Feb 24
4
JEFFREY L EDWARDS
2 Feb 24
4
Raymond H Diradoorian
2 Feb 24
4
LOVAS KATRINA HOUDE
2 Feb 24
4
Craig A. Barbarosh
2 Feb 24
4
John D Morberg
22 Jan 24